Singapore National Eye Centre
92
9
11
58
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.3%
3 terminated/withdrawn out of 92 trials
95.1%
+8.6% vs industry average
14%
13 trials in Phase 3/4
3%
2 of 58 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (92)
Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates
Role: collaborator
Detection and Optimization of Treatment of Severe Cases of Dry Eye Disease
Role: lead
Altered Non-Visual Photoreception in Patients With Glaucoma: Impacts on Sleep, Alertness, Mood, and Cognition
Role: collaborator
Telemedicine for Evaluating Dry Eye Disease (DED) Using a Mobile Phone-Attached Portable Automatic Ocular Surface Imaging Device (PAOSID): A Patient-Operated Diagnostic and Continuous Ocular Surface Monitoring (COSM) System
Role: lead
Atropine in the Treatment of Myopia Study in Malaysia
Role: collaborator
Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy
Role: lead
Choroidal Venous Congestion Following Scleral Buckling - An Imaging Study
Role: lead
Progression Patterns of Choroidal Venous Alterations
Role: lead
Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting
Role: lead
Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
Role: lead
Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)
Role: lead
Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
Role: lead
Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID)
Role: collaborator
The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
Role: lead
Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis
Role: lead
Healthy Living Through Personalized Monitoring of Eyelid Care
Role: lead
Herbal Medication to Treat Dry Eye in Peri/ Post-menopausal Women
Role: lead
Highly Aspherical Lenslet (HAL) and Binocular Vision (BV) Disorders [HALT X(T) Study]
Role: lead
Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression
Role: lead
Nicotinamide Supplementation in Glaucoma
Role: collaborator